Emergent BioSolutions is down -8.4%, or -66c to $7.21.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EBS:
- Emergent BioSolutions to settle securities class action litigation for $40M
- Emergent BioSolutions Announces Agreement to Settle Securities Class Action Litigation
- Emergent BioSolutions awarded contract modification valued at $41.9M
- Emergent BioSolutions Awarded Research and Development Option valued at $41.9 Million for continued Advanced Development and Procurement of Ebanga™ Treatment for Ebola
- Largest borrow rate increases among liquid names